Contrast-associated kidney injury

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

The preferred term contrast-associated acute kidney injury separates chronology from causation. Serum creatinine may rise after a contrast-enhanced scan because the patient was already becoming unwell, received a haemodynamic insult, underwent an intervention or developed another renal process. Modern observational evidence has reduced earlier estimates of harm from intravenous iodinated contrast, and NICE updated its risk assessment in 2024: an eGFR below 30 mL/min/1.73 m² carries a small but increased risk. This supports focused precautions for advanced impairment while preserving access to diagnostically important imaging.

A useful pathway starts with the urgency and value of the examination. Emergency decisions centre on whether delay threatens life, limb or timely definitive treatment. Non-urgent work allows kidney screening, an appropriate eGFR, discussion of alternatives and planning around hydration and medicines. Route matters: intra-arterial delivery with first-pass renal exposure, a large dose or repeat administration within 24 hours increases concern compared with a routine intravenous diagnostic study. Renal transplant and active AKI also justify tailored multidisciplinary planning.

Prevention is not a ritual fluid prescription. Oral hydration is appropriate for many increased-risk adults, while selected high-risk inpatients may receive intravenous isotonic fluid after assessment for depletion and congestion. Post-exposure deterioration is managed as AKI, not with a contrast-specific antidote. Apply the current radiology protocol, contrast product information, diabetic-medicines policy and renal-referral standard to agent selection, medicine interruption, hydration and follow-up.

Key points

Contrast-associated AKI means an AKI occurring after contrast exposure; the timing does not prove that contrast caused it, particularly in acutely ill patients with sepsis, hypotension, surgery or other nephrotoxins.
Current NICE guidance describes a small but increased risk with eGFR below 30 mL/min/1.73 m²; risk discussion should be individual rather than treating modest stable CKD as an automatic contraindication.
When delay would be clinically significant, iodine-based contrast should not be withheld for a creatinine result or pre-hydration; the diagnostic benefit in emergency CT commonly outweighs the renal concern.
For non-urgent CT, screen for kidney disease, transplant, nephrology or urology follow-up and recent acute illness; a stable eGFR from the previous six months can support the decision under NICE guidance.
Encourage oral hydration before and after intravenous iodine contrast in adults at increased risk, unless fluid intake is restricted or unsafe; do not prescribe indiscriminate drinking in decompensated heart failure.
For particularly high-risk inpatients, consider protocol-led intravenous expansion with 0.9% sodium chloride or isotonic sodium bicarbonate, balancing benefit against pulmonary oedema.
Use the lowest contrast exposure that still answers the clinical question and avoid unnecessary repeat or high-volume studies, but never compromise a required diagnostic examination without radiology input.
If creatinine rises afterwards, apply standard AKI criteria and search for all causes. Calling the episode ‘contrast nephropathy’ too early can conceal ongoing hypovolaemia, infection, obstruction or medicine toxicity.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Temporal iodinated-contrast exposure

An AKI arising after intravascular iodinated contrast is contrast-associated; temporal proximity alone does not establish that contrast caused the renal decline.

Reduced renal reserve

Advanced chronic kidney impairment or an evolving AKI increases susceptibility, especially when renal perfusion and tubular recovery are already compromised.

Concurrent acute insults

Sepsis, hypotension, surgery, hypovolaemia, heart failure, other nephrotoxins and repeated high-volume studies commonly coexist and may explain much of the observed injury.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Uncertain causal attribution
A creatinine rise after iodinated contrast is temporally associated; contrast causation should not be inferred until hypovolaemia, infection, obstruction and medicine toxicity are assessed.
2
Delayed creatinine response
When filtration falls, serum creatinine rises later and fluid balance can obscure the early trajectory, so timing requires cautious interpretation.
3
Multifactorial post-imaging AKI
Sepsis, hypotension, surgery, heart failure and nephrotoxins commonly surround contrast imaging, and several kidney insults may coexist in one episode.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Advanced stable kidney impairment

An eGFR below 30 mL/min/1.73 m² is the current NICE threshold associated with a small increase in risk. Confirm that the value reflects a stable state, because eGFR is unreliable when creatinine is changing acutely.

Active or suspected AKIRed flag

Recent vomiting, infection, hypotension, oliguria or a rising creatinine suggests acute dysfunction and makes an old eGFR unsuitable. Clarify urgency, correct reversible physiology and involve radiology or nephrology without obstructing essential emergency imaging.

High-exposure procedure

Intra-arterial contrast with first-pass renal exposure, more than a standard diagnostic volume, or repeat dosing within 24 hours are examples NICE uses to identify particularly high-risk inpatients for whom intravenous expansion may be considered.

Post-exposure AKI patternRed flag

A qualifying creatinine increase or sustained oliguria after contrast meets ordinary AKI criteria. Establish the time course and evaluate perfusion, sepsis, obstruction, urine findings and medicines before assigning causality.

Emergency diagnostic priorityRed flag

Possible aortic catastrophe, major haemorrhage, stroke pathway, bowel ischaemia, trauma or another time-critical diagnosis shifts the balance strongly toward immediate indicated imaging. Renal precautions run alongside rather than ahead of diagnosis.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Clinical urgency and imaging questionFirst step
Why
Decide whether any renal assessment can safely occur before contrast and whether contrast is essential to answer the question.
Interpretation and limitations
A senior requester should state the suspected emergency and consequence of delay. Discuss a genuinely equivalent non-contrast or alternative modality with radiology, but do not substitute a less diagnostic test simply to avoid a theoretical risk.
02
Serum creatinine and estimated GFR
Why
Identify advanced stable impairment and provide a baseline for selected non-urgent or high-risk examinations.
Interpretation and limitations
For a clinically stable non-urgent patient, NICE allows an available eGFR from the previous six months to support decision-making. Use a more recent result after acute illness or instability, and recognise that eGFR equations assume steady creatinine.
03
Volume-status assessment
Why
Find correctable depletion and identify people in whom additional sodium-containing fluid could cause harm.
Interpretation and limitations
Review intake, losses, blood pressure, perfusion, jugular venous pressure, oedema, lungs and heart-failure history. Hydration means restoration or maintenance of euvolaemia, not a fixed volume for every patient.
04
Medication and exposure reconciliation
Why
Identify renal haemodynamic medicines, direct nephrotoxins, metformin and recent contrast that may alter the plan or consequences of AKI.
Interpretation and limitations
NICE advises considering temporary ACE inhibitor or ARB interruption for CKD with eGFR below 30. Metformin does not cause contrast AKI, but accumulation during severe renal deterioration raises lactic-acidosis concern; follow the current local and product-specific policy.
05
Post-procedure creatinine and urine output
Why
Detect clinically relevant AKI when baseline risk, symptoms or subsequent deterioration warrants monitoring.
Interpretation and limitations
Do not order indiscriminate blood tests after every routine scan. In a high-risk or unwell patient, compare with baseline using timed AKI thresholds, assess urine output and investigate alternative causes rather than relying on temporal association.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Sepsis-associated AKI

Infection, vasodilatation, inflammation and microcirculatory dysfunction often surround emergency imaging; haemodynamic and microbiological trajectories may better explain the creatinine rise than contrast timing.

Hypovolaemic or haemodynamic AKI

Fluid loss, bleeding, low cardiac output or venous congestion supports a perfusion mechanism, particularly when kidney dysfunction began before imaging.

Other acute tubular injury

Surgery, shock and dose-related nephrotoxins can cause granular sediment and prolonged dysfunction; multiple tubular insults may coexist rather than allowing one causal label.

Urinary obstruction

Anuria, retention risk, pelvic disease or collecting-system dilatation suggests post-renal injury and requires action independent of the recent scan.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Emergency scanProtect diagnosis while managing renal riskFirst stepContrast imaging is required for a condition in which delay may cause clinically important harm.

11. Confirm the time-critical clinical question with the responsible senior clinician and communicate known AKI, transplant status or advanced CKD to radiology.
22. Proceed without making creatinine measurement or prophylactic intravenous fluid a prerequisite, in keeping with NICE and the joint RCR–RCEM emergency position.
33. Resuscitate shock or sepsis and avoid preventable additional nephrotoxins in parallel, tailoring any fluid to perfusion and congestion rather than to contrast exposure alone.
44. Arrange post-scan renal observation when the illness or baseline kidney state warrants it, and treat a subsequent AKI by physiology and cause.

02Planned studyScreen and reduce modifiable exposureAn outpatient, community or non-urgent inpatient iodine-contrast CT is being considered.

11. Ask about kidney disease or transplant, renal or urological follow-up, and acute symptoms such as vomiting, fever, infection, hypovolaemia or difficulty passing urine.
22. Use a suitable recent eGFR when kidney disease or possible AKI is identified; a stable person with negative screening questions may proceed without an additional blood test under the NICE pathway.
33. Discuss benefit, small residual renal risk and meaningful alternatives, then agree a protocol that preserves diagnostic quality and avoids unnecessary repeat or excessive contrast.
44. Encourage safe oral hydration for increased-risk adults and document any medicine interruption, review date and responsibility for restarting it.

03High-risk inpatientConsider monitored intravenous expansioneGFR below 30, renal transplant, large or repeated dose, or first-pass intra-arterial exposure creates particularly high risk.

11. Assess intravascular volume, heart failure, sodium load and oxygenation, and discuss procedure timing and contrast strategy with the radiology or interventional team.
22. If appropriate, prescribe local-protocol 0.9% sodium chloride or isotonic sodium bicarbonate with explicit rate, duration and reassessment points; reduce or omit it when overload risk predominates.
33. Consider temporary ACE inhibitor or ARB interruption when CKD eGFR is below 30, and follow local guidance for metformin and other renally cleared medicines.
4Escalation4. Monitor renal function and fluid state proportionately afterwards, escalating promptly if potassium, acidosis, oliguria or pulmonary oedema develops.

Key medicines and prescribing safety2 treatments · regimens, roles and cautions

Provides isotonic volume expansion when the team judges prophylaxis appropriate and the person can safely tolerate sodium and fluid.

Sodium chloride 0.9% intravenous infusion

For selected particularly high-risk inpatients, use the current radiology and intravenous-fluid protocol; prescribe an individualised rate and duration rather than copying a universal regimen.

Can precipitate pulmonary oedema, worsen venous congestion and cause hyperchloraemia. Examine the patient, account for other infusions and losses, and stop or alter the plan if respiratory or congestive signs emerge.

Offers protocolised isotonic expansion where the imaging service selects bicarbonate rather than sodium chloride; evidence does not justify improvised dosing.

Isotonic sodium bicarbonate intravenous infusion

An alternative NICE-listed expansion fluid for particularly high-risk inpatients; concentration, preparation, rate and timing must follow the approved local contrast protocol.

Check sodium, bicarbonate, fluid status and preparation accuracy. Avoid unmonitored administration in overload, alkalosis or severe sodium disturbance, and do not delay an emergency scan to complete it.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Persistent acute kidney injury

A multi-causal post-imaging decline may continue beyond the expected short biochemical fluctuation, requiring renewed assessment rather than attribution to contrast alone.

Electrolyte and fluid disturbance

Severe loss of filtration can cause hyperkalaemia, acidosis, oliguria and pulmonary congestion, while excessive preventive fluid may itself worsen heart failure.

Kidney replacement requirement

A small subset with severe underlying illness and renal injury may need temporary dialysis for dangerous physiology, not simply for the contrast exposure.

Residual chronic impairment

Incomplete recovery from the overall AKI episode can leave lower renal reserve and greater susceptibility to future acute and chronic kidney disease.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

During any prescribed intravenous expansion, monitor observations, oxygen requirement, lungs, oedema and cumulative balance; prophylaxis should be stopped and reviewed if congestion develops.
In active AKI or major acute illness, trend creatinine, potassium, bicarbonate and urine output at a frequency driven by clinical trajectory rather than by the scan schedule.
Record contrast route, approximate exposure and repeat administrations so later teams can interpret a renal change and avoid an unnecessary closely repeated elective dose.
Track all temporarily interrupted medicines with an explicit restart criterion, especially renin–angiotensin system therapy prescribed for heart failure or albuminuric kidney disease.
If post-exposure AKI occurs, monitor the complete physiological syndrome—perfusion, fluid state, ECG when potassium is raised and urinalysis—not merely the peak creatinine.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Association is not attribution

A creatinine rise following CT has many plausible causes in emergency patients. The phrase contrast-associated preserves diagnostic humility and prompts continued assessment for sepsis, haemodynamic injury, obstruction and drug toxicity.

The risk threshold changed

The 2024 NICE update centres the increased-risk discussion on eGFR below 30 mL/min/1.73 m² and describes the excess risk as small, helping prevent reflex cancellation in stable moderate CKD.

Emergency benefit dominates process

The joint RCR–RCEM statement says renal testing and intravenous fluid are not prerequisites for emergency contrast CT. This removes workflow barriers; it does not remove the duty to manage the patient’s underlying renal risks.

Metformin is a consequence issue

Metformin is not directly nephrotoxic and stopping it does not prevent contrast-associated AKI. Concern arises if AKI causes accumulation, so decisions should follow renal function, the product information and local imaging policy.

Transplant requires context

NICE advises nephrology discussion before contrast in people receiving renal replacement therapy, including transplant recipients, but explicitly says not to delay emergency imaging for that conversation.

11Common pitfallsFrequent interpretation and management errors.

01
Cancelling a clinically necessary emergency scan because no creatinine is available can create greater and more immediate harm than the small renal risk being avoided.
02
Calling every post-scan creatinine rise ‘contrast-induced’ prematurely closes the differential and may leave shock, infection, obstruction or another nephrotoxin untreated.
03
Giving fixed-volume prophylaxis to a patient with decompensated heart failure can cause pulmonary oedema; hydration must be an assessed prescription with endpoints.
04
Treating all eGFR values below 60 as equivalent ignores the current NICE emphasis on the small increased risk below 30 and drives unnecessary testing and delay.
05
Stopping prognostic ACE inhibitor or ARB therapy without a documented review and restart plan can convert a short precaution into long-term cardiovascular and renal undertreatment.